TVTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.19%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $12,860,345.10

Travere Therapeutics Insider Trading History Chart

Travere Therapeutics Share Price & Price History

^$35.33

▲ +0.48 (1.38%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Travere Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/1/2025	Christopher R. Cline	CFO	Sell	20,000	$35.01	$700,200.00	92,083
11/4/2025	Sandra Calvin	CAO	Sell	67,115	$36.00	$2,416,140.00	48,545
10/31/2025	Peter Heerma	Insider	Sell	5,591	$35.00	$195,685.00	119,071
10/31/2025	Timothy Coughlin	Director	Sell	18,000	$35.03	$630,540.00	55,500
10/29/2025	Eric M. Dube	CEO	Sell	27,128	$30.12	$817,095.36	419,173
10/28/2025	Eric M. Dube	CEO	Sell	92,872	$30.38	$2,821,451.36	419,173
10/28/2025	Peter Heerma	Insider	Sell	2,662	$30.00	$79,860.00	124,662
9/22/2025	Elizabeth E. Reed	Insider	Sell	10,000	$25.00	$250,000.00	89,878
9/4/2025	Christopher R. Cline	CFO	Sell	119	$19.71	$2,345.49	92,083
9/3/2025	Christopher R. Cline	CFO	Sell	454	$18.20	$8,262.80	92,202
7/1/2025	Jula Inrig	Insider	Sell	815	$14.65	$11,939.75	88,787
5/5/2025	Christopher R. Cline	CFO	Sell	1,784	$21.05	$37,553.20	93,126
5/5/2025	Eric M. Dube	CEO	Sell	18,924	$21.05	$398,350.20	419,173
5/5/2025	Peter Heerma	Insider	Sell	1,771	$21.05	$37,279.55	128,215
4/11/2025	Christopher R. Cline	CFO	Sell	48	$13.14	$630.72	89,990
2/12/2025	William E. Rote	SVP	Sell	5,200	$23.53	$122,356.00	98,519
2/11/2025	Eric M. Dube	CEO	Sell	11,375	$24.04	$273,455.00	419,173
2/11/2025	Peter Heerma	Insider	Sell	3,074	$25.00	$76,850.00	127,634
2/11/2025	Sandra Calvin	CAO	Sell	54,244	$25.00	$1,356,100.00	54,410
2/6/2025	Roy D. Baynes	Director	Sell	10,000	$22.00	$220,000.00	31,000
2/3/2025	Christopher R. Cline	CFO	Sell	5,192	$20.12	$104,463.04	90,038
2/3/2025	Eric M. Dube	CEO	Sell	50,691	$20.21	$1,024,465.11	430,548
2/3/2025	Jula Inrig	Insider	Sell	4,207	$20.12	$84,644.84	85,236
2/3/2025	Sandra Calvin	CAO	Sell	3,348	$20.12	$67,361.76	63,654
2/3/2025	William E. Rote	SVP	Sell	8,951	$19.78	$177,050.78	95,719
1/23/2025	Roy D. Baynes	Director	Sell	16,000	$20.00	$320,000.00	31,000
1/22/2025	Christopher R. Cline	CFO	Sell	865	$18.94	$16,383.10	73,730
1/22/2025	Eric M. Dube	CEO	Sell	10,736	$19.46	$208,922.56	351,239
1/22/2025	Peter Heerma	Insider	Sell	1,584	$18.94	$30,000.96	106,374
1/22/2025	Sandra Calvin	CAO	Sell	925	$18.94	$17,519.50	54,002
1/22/2025	William E. Rote	SVP	Sell	2,437	$19.46	$47,424.02	83,170
1/6/2025	Jula Inrig	Insider	Sell	440	$18.76	$8,254.40	59,443
1/3/2025	Jula Inrig	Insider	Sell	2,066	$19.10	$39,460.60	59,883
12/26/2024	Sandra Calvin	CAO	Sell	15,000	$17.22	$258,300.00	54,927
11/25/2024	Sandra Calvin	CAO	Sell	12,090	$18.30	$221,247.00	54,927
10/4/2024	Gary A Lyons	Director	Sell	40,000	$14.73	$589,200.00	51,000
9/30/2024	Jeffrey A Meckler	Director	Sell	40,000	$14.06	$562,400.00	81,000
9/9/2024	Christopher R. Cline	CFO	Sell	2,490	$11.52	$28,684.80	74,595
9/9/2024	Eric M. Dube	CEO	Sell	21,125	$11.52	$243,360.00	361,975
9/9/2024	Jula Inrig	Insider	Sell	2,191	$11.52	$25,240.32	62,633
9/9/2024	William E. Rote	SVP	Sell	4,387	$11.52	$50,538.24	84,455
9/4/2024	Christopher R. Cline	CFO	Sell	514	$9.51	$4,888.14	70,335
4/11/2024	Christopher R. Cline	CFO	Sell	54	$6.74	$363.96	70,849
2/1/2024	Christopher R. Cline	CFO	Sell	3,818	$8.53	$32,567.54	70,903
2/1/2024	Eric M. Dube	CEO	Sell	19,122	$8.70	$166,361.40	350,600
2/1/2024	Peter Heerma	Insider	Sell	4,195	$8.53	$35,783.35	99,503
2/1/2024	Sandra Calvin	CAO	Sell	2,820	$8.53	$24,054.60	52,017
2/1/2024	William E. Rote	SVP	Sell	4,764	$8.71	$41,494.44	80,720
1/23/2024	Christopher R. Cline	CFO	Sell	853	$9.07	$7,736.71	49,721
1/23/2024	Elizabeth E. Reed	SVP	Sell	2,062	$8.96	$18,475.52	56,034
1/23/2024	Eric M. Dube	CEO	Sell	7,873	$8.96	$70,542.08	234,722
1/23/2024	Peter Heerma	Insider	Sell	1,559	$9.07	$14,140.13	78,698
1/23/2024	Sandra Calvin	CAO	Sell	910	$9.07	$8,253.70	41,337
1/3/2024	Jula Inrig	Insider	Sell	2,069	$9.48	$19,614.12	35,688
10/3/2023	Peter Heerma	Insider	Sell	3,091	$8.25	$25,500.75	80,257
9/5/2023	Christopher R. Cline	CFO	Sell	457	$14.71	$6,722.47	50,574
9/5/2023	Eric M. Dube	CEO	Sell	4,455	$14.71	$65,533.05	242,595
9/5/2023	William E. Rote	SVP	Sell	1,815	$14.71	$26,698.65	61,173
5/10/2023	Christopher R. Cline	CFO	Sell	455	$16.59	$7,548.45	51,031
5/10/2023	Elizabeth E. Reed	SVP	Sell	825	$16.59	$13,686.75	56,611
5/10/2023	Sandra Calvin	CAO	Sell	436	$16.59	$7,233.24	42,369
4/11/2023	Christopher R. Cline	CFO	Sell	47	$21.49	$1,010.03	51,486
2/1/2023	Christopher R. Cline	CFO	Sell	1,588	$21.75	$34,539.00	51,533
2/1/2023	Elizabeth E. Reed	SVP	Sell	2,590	$22.25	$57,627.50	57,436
2/1/2023	Eric M. Dube	CEO	Sell	8,196	$22.25	$182,361.00	237,150
2/1/2023	Peter Heerma	Insider	Sell	1,779	$21.75	$38,693.25	82,069
2/1/2023	Sandra Calvin	CAO	Sell	1,671	$21.75	$36,344.25	43,165
1/24/2023	Christopher R. Cline	CFO	Sell	852	$21.90	$18,658.80	32,871
1/24/2023	Eric M. Dube	CEO	Sell	6,442	$21.50	$138,503.00	147,846
1/24/2023	Peter Heerma	Insider	Sell	1,550	$21.90	$33,945.00	63,598
1/24/2023	Sandra Calvin	CAO	Sell	905	$21.90	$19,819.50	35,028
1/24/2023	William E. Rote	SVP	Sell	2,062	$21.50	$44,333.00	42,376
1/5/2023	Eric M. Dube	CEO	Sell	5,625	$20.75	$116,718.75	154,288
1/4/2023	Jula Inrig	Insider	Sell	2,051	$20.75	$42,558.25	17,949

SEC Filings (Institutional Ownership Changes) for Travere Therapeutics (NASDAQ:TVTX)

Institutional Buying and Selling by Quarter

Travere Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/24/2025	Penn Capital Management Company LLC	27,004	$0.65M	0.0%	+39.7%	0.030%
11/21/2025	CIBC Bancorp USA Inc.	9,398	$0.23M	0.0%	N/A	0.011%
11/17/2025	Jacobs Levy Equity Management Inc.	318,146	$7.60M	0.0%	-56.7%	0.356%
11/17/2025	Armistice Capital LLC	6,724,000	$160.70M	2.4%	-24.2%	7.515%
11/17/2025	Woodline Partners LP	89,328	$2.14M	0.0%	-82.2%	0.100%
11/17/2025	PDT Partners LLC	281,458	$6.73M	0.4%	-19.5%	0.315%
11/17/2025	Dark Forest Capital Management LP	28,483	$0.68M	0.0%	-46.5%	0.032%
11/17/2025	PharVision Advisers LLC	8,799	$0.21M	0.1%	N/A	0.010%
11/17/2025	Voloridge Investment Management LLC	883,672	$21.12M	0.1%	+18.7%	0.988%
11/17/2025	Quarry LP	14,960	$0.36M	0.1%	+113.7%	0.017%
11/17/2025	Qube Research & Technologies Ltd	571,997	$13.67M	0.0%	-5.3%	0.639%
11/17/2025	Prelude Capital Management LLC	46,407	$1.11M	0.1%	-5.4%	0.052%
11/17/2025	Parkman Healthcare Partners LLC	339,764	$8.12M	0.8%	-58.9%	0.380%
11/17/2025	Militia Capital Partners LP	15,400	$0.37M	0.2%	N/A	0.017%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	45,573	$1.09M	0.0%	-16.4%	0.051%
11/17/2025	Jain Global LLC	32,117	$0.77M	0.0%	N/A	0.036%
11/17/2025	Gotham Asset Management LLC	27,743	$0.66M	0.0%	N/A	0.031%
11/17/2025	Fred Alger Management LLC	122,029	$2.92M	0.0%	N/A	0.136%
11/17/2025	Brevan Howard Capital Management LP	42,505	$1.02M	0.0%	N/A	0.048%
11/17/2025	Cinctive Capital Management LP	94,656	$2.26M	0.1%	N/A	0.106%
11/17/2025	Algert Global LLC	153,648	$3.67M	0.1%	+20.8%	0.172%
11/17/2025	Alliancebernstein L.P.	322,115	$7.70M	0.0%	-6.3%	0.360%
11/17/2025	Apis Capital Advisors LLC	166,000	$3.97M	0.9%	N/A	0.186%
11/14/2025	Schonfeld Strategic Advisors LLC	16,872	$0.40M	0.0%	-70.0%	0.019%
11/14/2025	Creative Planning	36,807	$0.88M	0.0%	+16.4%	0.041%
11/14/2025	Man Group plc	29,727	$0.71M	0.0%	-78.6%	0.033%
11/14/2025	California State Teachers Retirement System	79,936	$1.91M	0.0%	+10.7%	0.089%
11/14/2025	Fiduciary Trust Co	9,461	$0.23M	0.0%	N/A	0.011%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	145,927	$3.49M	0.0%	-67.2%	0.163%
11/14/2025	Two Sigma Investments LP	928,998	$22.20M	0.0%	+1.1%	1.038%
11/14/2025	Squarepoint Ops LLC	114,477	$2.74M	0.0%	-76.1%	0.128%
11/14/2025	Wellington Management Group LLP	1,201,469	$28.72M	0.0%	+3,331.9%	1.343%
11/14/2025	F m Investments LLC	196,074	$4.69M	0.2%	+4.4%	0.219%
11/13/2025	Jump Financial LLC	315,030	$7.53M	0.1%	N/A	0.352%
11/13/2025	Marshall Wace LLP	590,051	$14.10M	0.0%	-20.6%	0.659%
11/13/2025	Entropy Technologies LP	16,793	$0.40M	0.0%	N/A	0.019%
11/13/2025	Arrowstreet Capital Limited Partnership	328,654	$7.86M	0.0%	N/A	0.367%
11/13/2025	Invesco Ltd.	627,902	$15.01M	0.0%	+22.9%	0.702%
11/13/2025	Sei Investments Co.	49,432	$1.18M	0.0%	-38.3%	0.055%
11/13/2025	Connor Clark & Lunn Investment Management Ltd.	857,899	$20.50M	0.1%	+25.1%	0.959%
11/13/2025	Capital Fund Management S.A.	41,512	$0.99M	0.0%	-59.1%	0.046%
11/13/2025	BNP Paribas Financial Markets	565,597	$13.52M	0.0%	+223.1%	0.632%
11/13/2025	Mackenzie Financial Corp	50,370	$1.20M	0.0%	-16.5%	0.056%
11/13/2025	Franklin Resources Inc.	34,724	$0.83M	0.0%	-54.6%	0.039%
11/13/2025	Quadrant Capital Group LLC	6,622	$0.16M	0.0%	N/A	0.007%
11/13/2025	Legal & General Group Plc	520,592	$12.44M	0.0%	+2.0%	0.582%
11/13/2025	Swiss National Bank	163,600	$3.91M	0.0%	+1.6%	0.183%
11/13/2025	Russell Investments Group Ltd.	222,257	$5.31M	0.0%	-82.6%	0.248%
11/13/2025	Schroder Investment Management Group	62,293	$1.50M	0.0%	-85.2%	0.070%
11/13/2025	Inceptionr LLC	10,487	$0.25M	0.1%	N/A	0.012%
11/13/2025	First Trust Advisors LP	172,430	$4.12M	0.0%	-27.9%	0.193%
11/12/2025	Barclays PLC	349,002	$8.34M	0.0%	-52.4%	0.390%
11/12/2025	GW&K Investment Management LLC	117,869	$2.82M	0.0%	-58.3%	0.132%
11/12/2025	Legato Capital Management LLC	71,030	$1.70M	0.2%	N/A	0.079%
11/12/2025	Teachers Retirement System of The State of Kentucky	30,635	$0.73M	0.0%	N/A	0.034%
11/12/2025	Victory Capital Management Inc.	45,535	$1.09M	0.0%	+84.7%	0.051%
11/12/2025	Fisher Asset Management LLC	39,341	$0.94M	0.0%	-8.9%	0.044%
11/12/2025	Royce & Associates LP	123,250	$2.95M	0.0%	-67.7%	0.138%
11/12/2025	Rafferty Asset Management LLC	90,250	$2.16M	0.0%	-27.1%	0.101%
11/12/2025	Intech Investment Management LLC	27,542	$0.66M	0.0%	-29.4%	0.031%
11/12/2025	Fox Run Management L.L.C.	11,249	$0.27M	0.0%	N/A	0.013%
11/10/2025	Ameritas Investment Partners Inc.	7,366	$0.18M	0.0%	-13.4%	0.008%
11/10/2025	Hillsdale Investment Management Inc.	178,400	$4.26M	0.1%	+9.2%	0.199%
11/10/2025	China Universal Asset Management Co. Ltd.	15,625	$0.37M	0.0%	-12.4%	0.017%
11/7/2025	Vanguard Group Inc.	6,613,368	$158.06M	0.0%	+10.3%	7.392%
11/7/2025	Shell Asset Management Co.	2,142	$51K	0.0%	-60.3%	0.002%
11/7/2025	Aberdeen Group plc	967,385	$23.12M	0.0%	+7.9%	1.081%
11/6/2025	Rhumbline Advisers	130,021	$3.11M	0.0%	-1.5%	0.146%
11/6/2025	Baader Bank Aktiengesellschaft	13,000	$0.31M	0.0%	N/A	0.015%
11/6/2025	Essex Investment Management Co. LLC	161,988	$3.87M	0.6%	N/A	0.182%
11/6/2025	S&CO Inc.	56,000	$1.34M	0.1%	+100.0%	0.063%
11/6/2025	Profund Advisors LLC	20,238	$0.48M	0.0%	-22.9%	0.023%
11/6/2025	ProShare Advisors LLC	18,251	$0.44M	0.0%	-14.7%	0.020%
11/5/2025	Alps Advisors Inc.	47,243	$1.13M	0.0%	-1.5%	0.053%
11/4/2025	Penserra Capital Management LLC	80,556	$1.93M	0.0%	N/A	0.090%
11/4/2025	Lisanti Capital Growth LLC	129,512	$3.10M	0.8%	N/A	0.145%
11/3/2025	AlphaQuest LLC	5,464	$0.13M	0.0%	-84.5%	0.006%
11/3/2025	Arizona State Retirement System	24,964	$0.60M	0.0%	+1.5%	0.028%
11/3/2025	Federated Hermes Inc.	16,711	$0.40M	0.0%	-96.8%	0.019%
11/3/2025	Hussman Strategic Advisors Inc.	42,000	$1M	0.2%	-75.0%	0.047%
10/31/2025	Y Intercept Hong Kong Ltd	94,325	$2.25M	0.1%	+38.7%	0.106%
10/30/2025	Emerald Mutual Fund Advisers Trust	1,200,942	$28.70M	1.5%	+5.2%	1.347%
10/30/2025	Emerald Advisers LLC	2,146,767	$51.31M	1.6%	+2.6%	2.408%
10/30/2025	Universal Beteiligungs und Servicegesellschaft mbH	213,918	$5.11M	0.0%	+67.7%	0.240%
10/29/2025	Oak Ridge Investments LLC	68,232	$1.63M	0.1%	+32.5%	0.077%
10/28/2025	Stephens Investment Management Group LLC	1,599,668	$38.23M	0.5%	N/A	1.795%
10/28/2025	Campbell & CO Investment Adviser LLC	48,191	$1.15M	0.1%	+195.4%	0.054%
10/27/2025	First Horizon Corp	1,526	$36K	0.0%	N/A	0.002%
10/23/2025	SG Americas Securities LLC	43,950	$1.05M	0.0%	+37.7%	0.049%
10/22/2025	Hennion & Walsh Asset Management Inc.	36,810	$0.88M	0.0%	+70.0%	0.041%
10/20/2025	Diversified Trust Co	23,695	$0.57M	0.0%	+3.5%	0.027%
10/16/2025	Rice Hall James & Associates LLC	84,097	$2.01M	0.1%	-10.2%	0.094%
10/15/2025	CWM LLC	11,459	$0.27M	0.0%	+265.1%	0.013%
10/9/2025	Voya Investment Management LLC	194,854	$4.66M	0.0%	+16.2%	0.219%
10/7/2025	Assenagon Asset Management S.A.	93,355	$2.23M	0.0%	-91.5%	0.105%
8/27/2025	Squarepoint Ops LLC	479,394	$7.10M	0.0%	+98.7%	0.538%
8/16/2025	Headlands Technologies LLC	4,936	$73K	0.0%	N/A	0.006%
8/15/2025	Tower Research Capital LLC TRC	24,998	$0.37M	0.0%	+609.4%	0.028%
8/15/2025	Rafferty Asset Management LLC	123,854	$1.83M	0.0%	-14.6%	0.139%
8/15/2025	Perceptive Advisors LLC	834,252	$12.35M	1.1%	N/A	0.936%

Data available starting January 2016

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. Its products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. The company's clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase (TVT-058), a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences and Alagille Syndrome Alliance for the identification of potential small molecule therapeutics for Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Today's Range

Now: $35.33

$34.45

$35.63

50 Day Range

MA: $30.85

$23.90

$36.47

52 Week Range

Now: $35.33

$12.91

$37.50

Volume

1,433,654 shs

Average Volume

1,513,398 shs

Market Capitalization

$3.16 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.89

Who are the company insiders with the largest holdings of Travere Therapeutics?: Travere Therapeutics' top insider investors include:
Eric M Dube (CEO)
Peter Heerma (Insider)
William E Rote (SVP)
Christopher R Cline (CFO)
Elizabeth E Reed (Insider)
Jula Inrig (Insider)
Jeffrey A Meckler (Director)
Sandra Calvin (CAO)
Elizabeth E Reed (SVP)
Timothy Coughlin (Director)
Gary A Lyons (Director)
Roy D Baynes (Director)
Learn More about top insider investors at Travere Therapeutics.
Who are the major institutional investors of Travere Therapeutics?: Travere Therapeutics' top institutional shareholders include:
Armistice Capital LLC — 7.52%
Vanguard Group Inc. — 7.39%
Emerald Advisers LLC — 2.41%
Stephens Investment Management Group LLC — 1.79%
Wellington Management Group LLP — 1.34%
Emerald Mutual Fund Advisers Trust — 1.35%
Learn More about top institutional investors of Travere Therapeutics stock.
Which institutional investors are selling Travere Therapeutics stock?: In the previous quarter, TVTX stock was sold by these institutional investors:
Armistice Capital LLC
Russell Investments Group Ltd.
Assenagon Asset Management S.A.
Federated Hermes Inc.
Parkman Healthcare Partners LLC
Jacobs Levy Equity Management Inc.
Woodline Partners LP
Barclays PLC
In the previous year, company insiders that have sold Travere Therapeutics company stock include:
Eric M Dube (CEO)
Peter Heerma (Insider)
William E Rote (SVP)
Christopher R Cline (CFO)
Elizabeth E Reed (Insider)
Jula Inrig (Insider)
Jeffrey A Meckler (Director)
Sandra Calvin (CAO)
Elizabeth E Reed (SVP)
Learn More investors selling Travere Therapeutics stock.
Which institutional investors are buying Travere Therapeutics stock?: In the last quarter, TVTX stock was bought by institutional investors including:
Stephens Investment Management Group LLC
Wellington Management Group LLP
Vanguard Group Inc.
BNP Paribas Financial Markets
Arrowstreet Capital Limited Partnership
Jump Financial LLC
Connor Clark & Lunn Investment Management Ltd.
Apis Capital Advisors LLC